SEC Form 4/A · accession 0001144204-16-084833
China Biologic Products, Inc. · CBPO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
David Hui Li
Director
Period of report
Feb 22, 2016
Accepted (ET)
Feb 29, 2016 · 11:44 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted StockF1 | Feb 22, 2016 | A | 5,000 | $0.00 | A | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the grant of restricted stock to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a restricted stock grant agreement dated February 22, 2016 (the "Restricted Stock Agreement"). The restricted stock will vest and the Issuer's right to reacquire the restricted stock will lapse over a 24-month period in two equal portions, with an initial vesting date on February 23, 2017, provided that the Reporting Person has been continuously a Service Provider (as defined in the Restricted Stock Agreement) from February 22, 2016 until the date such vesting occurs.
Remarks
* The Reporting Person ceased to be a Managing Director and Member of Warburg Pincus LLC, a New York limited liability company ("WP LLC"), on January 31, 2016, and therefore, the Reporting Person may no longer be deemed to have an indirect pecuniary interest (within the meaning of Rule 16a-1 under the Securities and Exchange Act of 1934, as amended) in an indeterminate portion of the Issuer's common stock reported as beneficially owned by the affiliated entities of WP LLC. ** This Form 4 is filed late due to administrative oversight.